File on 4 Investigates Folgen

The UK's £12 billion pound foreign aid budget is one of the few areas of Government spending protected from cuts. The commitment to spend 0.7% of Britain's gross national income on aid means at least 60 billion pounds will be spent on overseas development in the next five years. Many of these projects are delivered by large companies that receive tens of millions of pounds from DFID (the Department for International Development). They can charge over a thousand pounds a day for a consultant and their directors earn six figure salaries but how effective are they are and the programmes they are paid to deliver? Simon Cox investigates the UK's aid industry and asks how taxpayers can know that they're getting value for money. Reporter: Simon Cox Producer: Gail Champion.

Sixty thousand people have crossed the Mediterranean and made it to Europe so far this year.Frontex, the EU border agency, warns that between 500,000 and 1 million people - Eritreans, Syrians, Afghans, Somalis - could be waiting to leave the shores of Libya for Italy.Its latest report says resources are being devoted to migrants' care but not towards screening and collecting basic information such as their nationality - which means many are quickly moving on to countries like the UK. According to the report, 'this puts the EU internal security at risk'.There are also fears terrorists belonging to the so-called Islamic State could secrete themselves among the migrants.So how easy is it for people to avoid security checks as they journey across the EU?European countries are supposed to stop illegal migrants and enter their fingerprints and details on a central database. EU rules state that the country where people are first fingerprinted must look after them and consider their asylum applications.This means many migrants set on coming to this country try to stay under the radar in Italy and France, hoping to reach the UK without being processed.Jane Deith follows the routes used by some of those headed for Britain.She also investigates the smugglers who help them - from individuals using their own cars, to organized crime gangs offering money back guarantees on a new life in the UK.Is Europe losing the battle for control?Reporter: Jane Deith Producer: Paul Grant.

Later this month the medicines regulator, the MHRA, is due to complete its review into the clot-busting drug Alteplase, the frontline treatment used in many cases of stroke. A number of experts in the UK, US and Canada have raised serious doubts about the drug's safety and effectiveness. They are concerned about potentially fatal harm to patients through an increased risk of bleeding in the brain and they question the credibility of scientific research on which Alteplase was licensed. Supporters and regulators say any risks are outweighed by the benefits of improved recovery. BBC Health Correspondent Adam Brimelow assesses the evidence and the dilemma posed for doctors and their patients. Producer: Sally Chesworth.